Humedix Co., Ltd. (200670)
KRX SM KRX SM Primary Summary
Humedix Co., Ltd. (200670) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Humedix Co., Ltd. ever had a stock split?
Humedix Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | KR7200670008 ISIN |
| South Korea Country | - Employees | 26 May 2026 Last Dividend | 27 Dec 2018 Last Split | - IPO Date |
Overview
Humedix Co., Ltd. is a significant player in the pharmaceutical industry, primarily operating within South Korea. The company's journey began in 2002, marking its foundation in an industry where innovation and quality are paramount. Initially known as HVLS Co., Ltd., the company underwent a strategic rebranding in 2010, adopting the name Humedix Co., Ltd. This rebranding reflected its broader vision and commitment to enhancing human health through its products. Humedix has established its headquarters in Seongnam-si, South Korea, from where it oversees its operations, including the manufacture and sale of a diverse range of pharmaceutical products. Its portfolio not only includes prescription medicines which are critical in treating various health conditions but also spans to active pharmaceutical ingredients essential for drug manufacturing. Furthermore, Humedix has expanded its offerings to encompass medical devices, cosmetics, and health functional food products, catering to a broad spectrum of healthcare and wellness needs. The company also specialises in the development and distribution of anticancer drugs, underscoring its role in advancing cancer treatment options.
Products and Services
- Prescription Medicines
- Active Pharmaceutical Ingredients (APIs)
- Medical Devices
- Cosmetics
- Health Functional Food Products
- Anticancer Drugs
Humedix Co., Ltd. develops and markets a variety of prescription medicines aimed at treating various diseases and health conditions. These products are the backbone of the company's pharmaceutical offerings, ensuring patients receive the necessary medications for their health issues.
The company is involved in the production of active pharmaceutical ingredients, which are crucial components in drug development and manufacturing. APIs from Humedix serve as the building blocks for many medications, highlighting their importance in the pharmaceutical supply chain.
Humedix extends its expertise into the medical devices sector, offering products that aid in diagnosis, treatment, and patient care. These devices are integral to modern healthcare, providing essential functionalities to healthcare facilities and improving patient outcomes.
Recognizing the growing demand for skincare and beauty products, Humedix has diversified its product range to include cosmetics. These products combine pharmaceutical knowledge with cosmetic needs, aiming to provide high-quality, effective skincare solutions.
The company also explores the intersection of nutrition and health by offering health functional food products. These products are designed to provide specific health benefits beyond basic nutrition, aligning with the increasing consumer focus on wellness and preventive health care.
Specializing in the manufacture and distribution of anticancer drugs, Humedix plays a pivotal role in the fight against cancer. These drugs represent a critical segment of the company's product portfolio, focusing on providing effective treatment options for cancer patients.
